Quick Answer
AbCellera Biologics Inc. reported Earnings Per Share Diluted of $0.49 (loss) per share for the year ending 2025.
- AbCellera Biologics Inc. showed an increase of +10.9% in Earnings Per Share Diluted from 2024 to 2025.
- This data is from AbCellera Biologics Inc.'s annual report (Form 10-K), filed with the SEC on February 24, 2026.
- XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 7 years of available data (2019 to 2025), AbCellera Biologics Inc.'s Earnings Per Share Diluted has declined by 4,800.0%.
- Historical annual values: Fiscal year 2025: $0.49 (loss) per share | Fiscal year 2024: $0.55 (loss) per share | Fiscal year 2023: $0.51 (loss) per share | Fiscal year 2022: $0.50 per share | Fiscal year 2021: $0.48 per share | Fiscal year 2020: $0.45 per share | Fiscal year 2019: $0.01 (loss) per share.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: